Monthly Archives: March 2013
Myelofibrosis Treatment Options
What are the treatment options for myelofibrosis? Experts Ross Levine, MD, Jill Vanak, ACNP-BC AOCNP, and Erica Fischer-Cartilidge, RN provide tips on talkin…
A quote for you...
Powered By Optimism Quotes
Myelofibrosis Treatment: Swami Iyer
Dr Swami Iyer from Methodist Hospital, Houston gave an update on the breakthroughs in treatment for myelofibrosis.
A quote for you...
Powered By Optimism Quotes
Managing Myelofibrosis Complications
What are the symptoms of myelofibrosis? How can these symptoms be managed? Ross Levine, MD, Jill Vanak ACNP-BC AOCNP and Erica Fischer-Cartilidge, RN discuss…
A quote for you...
Powered By Optimism Quotes
Myelofibrosis Emotional Support
People diagnosed with myelofibrosis may experience a variety of emotions. Learn about common emotions people may experience and tips to cope from experts Ros…
A quote for you...
Powered By Optimism Quotes
Ruxolitinib treatment in myelofibrosis – Video abstract: 24926
Video abstract of review paper “Ruxolitinib as an emerging treatment in myelofibrosis” published in the open access journal of Blood and Lymphatic Cancer: Targets and Therapy by Robyn M Emanuel, Holly L Geyer and Ruben A Mesa. Abstract: Essential thrombocythemia, polycythemia vera, and myelofibrosis belong to the class of Bcr-Abl… Continue reading
Interferon for Myeloproliferative Neoplasms: Current and Future Uses – Mayo Clinic
Hematologist Ruben Mesa, M.D., Chair, Division of Hematology and Oncology at Mayo Clinic in Arizona, discusses the latest on Interferon for Myeloproliferativ…
A quote for you...
Powered By Optimism Quotes
Dr. Mesa on the Evolving Role of JAK2 Inhibitors in Myelofibrosis
Ruben A. Mesa, MD, Professor of Medicine, Division of Hematology & Medical Oncology, Mayo Clinic, discusses the use of JAK2 inhibitors in patients with myelofibrosis. For more information regarding myelofibrosis and other hematologic malignancies, visit: www.onclive.com
A quote for you...
Powered By Optimism Quotes